Wyss, Jacqueline
Raselli, Tina
Wyss, Annika
Telzerow, Anja
Rogler, Gerhard
Krupka, Niklas
Yilmaz, Bahtiyar
Schmidt, Thomas S. B.
Misselwitz, Benjamin
Funding for this research was provided by:
Swiss National Science Foundation (Grant 32473B_156525)
Hartmann-Müller Foundation
European Molecular Biology Laboratory (EMBL)
Article History
Received: 6 September 2023
Accepted: 11 January 2024
First Online: 28 February 2024
Declarations
:
: Approval by the local animal welfare authority (Tierschutzkommision Zürich, Zurich, Switzerland; registration number ZH 50/2013.
: Not applicable.
: G.R. was supported by grants from AbbVie, Ardeypharm, MSD, Falk, Flamentera, Novartis, Roche, Tillots, UCB, and Zeller. B.M. has served on an advisory board for Takeda and BMS and has received traveling fees or speaking fees from Abbvie, MSD, Falk, iQONE, Gilead, and Novartis and has received unrestricted research grants from MSD and BMS unrelated to the current work.All other authors declare that they have no competing interests. No third party has influenced any aspect of this study.